Nitazene Control Act

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 3076 Introduced in Senate (IS)] <DOC> 119th CONGRESS 1st Session S. 3076 To amend the Controlled Substances Act to permanently schedule the class of 2-benzylbenzimidazole-opioids known as nitazenes, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES October 30, 2025 Mr. McCormick (for himself, Mr. Gallego, Mr. Ricketts, Mrs. Shaheen, Mr. Schmitt, Ms. Slotkin, and Mrs. Moody) introduced the following bill; which was read twice and referred to the Committee on the Judiciary _______________________________________________________________________ A BILL To amend the Controlled Substances Act to permanently schedule the class of 2-benzylbenzimidazole-opioids known as nitazenes, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Nitazene Control Act''. SEC. 2. FINDINGS. Congress finds the following: (1) 2-Benzylbenzimidazole opioids are a class of synthetic opioids first synthesized in the 1950s that exhibit significant potency at the mu-opioid receptor, with some substances exceeding the potency of fentanyl. (2) The Drug Enforcement Administration has temporarily or permanently scheduled multiple 2-benzylbenzimidazole opioids compounds under schedule I of section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) due to their high abuse potential and lack of accepted medical use. (3) Nitazenes and related compounds have emerged in the illicit drug supply as designer drugs and contribute to overdose and fatal poisonings in the United States. (4) A class-wide permanent scheduling of 2- benzylbenzimidazole opioids is necessary to preemptively address the proliferation of new analogs, streamline enforcement, and protect public health. (5) The HALT Fentanyl Act (28 U.